These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 15982605

  • 1. Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion.
    White M, Haddad H, Leblanc MH, Giannetti N, Pflugfelder P, Davies R, Isaac D, Burton J, Chan M, Azevedo E, Howlett J, Ignaszewski A, Busque S, Cantarovich M, Ferguson R, Genest J, Ross H.
    J Heart Lung Transplant; 2005 Jul; 24(7):798-809. PubMed ID: 15982605
    [Abstract] [Full Text] [Related]

  • 2. Subclinical inflammation and prothrombotic state in heart transplant recipients: impact of cyclosporin microemulsion vs. tacrolimus.
    White M, Ross H, Haddad H, LeBlanc MH, Racine N, Pflugfelder P, Giannetti N, Davies R, Azevedo E, Isaac D, Burton J, Ferguson R, Genest J.
    Transplantation; 2006 Sep 27; 82(6):763-70. PubMed ID: 17006323
    [Abstract] [Full Text] [Related]

  • 3. Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin.
    Skalicka B, Kubanek M, Malek I, Vymetalova Y, Hoskova L, Podzimkova M, Kautzner J.
    J Heart Lung Transplant; 2009 Jun 27; 28(6):598-604. PubMed ID: 19481021
    [Abstract] [Full Text] [Related]

  • 4. Tacrolimus conversion improves hyperlipidemic states in stable liver transplant recipients.
    Manzarbeitia C, Reich DJ, Rothstein KD, Braitman LE, Levin S, Munoz SJ.
    Liver Transpl; 2001 Feb 27; 7(2):93-9. PubMed ID: 11172391
    [Abstract] [Full Text] [Related]

  • 5. Effect of calcineurin inhibitors on low-density lipoprotein oxidation.
    Cofan F, Cofan M, Campos B, Guerra R, Campistol JM, Oppenheimer F.
    Transplant Proc; 2005 Nov 27; 37(9):3791-3. PubMed ID: 16386540
    [Abstract] [Full Text] [Related]

  • 6. Effects of cyclosporine-tacrolimus switching in posttransplantation hyperlipidemia on high-density lipoprotein 2/3, lipoprotein a1/b, and other lipid parameters.
    Seymen P, Yildiz M, Türkmen MF, Titiz MI, Seymen HO.
    Transplant Proc; 2009 Dec 27; 41(10):4181-3. PubMed ID: 20005364
    [Abstract] [Full Text] [Related]

  • 7. Conversion from cyclosporine microemulsion to tacrolimus in stable kidney transplant patients with hypercholesterolemia is related to an improvement in cardiovascular risk profile: a prospective study.
    Marcén R, Chahin J, Alarcón A, Bravo J.
    Transplant Proc; 2006 Oct 27; 38(8):2427-30. PubMed ID: 17097957
    [Abstract] [Full Text] [Related]

  • 8. Do blood pressure and arterial wall properties change after conversion from cyclosporine to tacrolimus?
    Gelens MA, Christiaans MH, v Hooff JP.
    Transplant Proc; 2005 May 27; 37(4):1900-1. PubMed ID: 15919498
    [Abstract] [Full Text] [Related]

  • 9. One-year observation of kidney allograft recipients converted from cyclosporine microemulsion to tacrolimus.
    Chamienia A, Biedunkiewicz B, Król E, Debska-Slizień A, Rutkowski B.
    Transplant Proc; 2006 May 27; 38(1):81-5. PubMed ID: 16504670
    [Abstract] [Full Text] [Related]

  • 10. Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients.
    Boots JM, van Duijnhoven EM, Christiaans MH, Nieman FH, van Suylen RJ, van Hooff JP.
    Transpl Int; 2001 Dec 27; 14(6):370-83. PubMed ID: 11793034
    [Abstract] [Full Text] [Related]

  • 11. Long term efficacy of simvastatin in renal transplant recipients treated with cyclosporine or tacrolimus.
    Imamura R, Ichimaru N, Moriyama T, Shi Y, Namba Y, Nonomura N, Matsumiya K, Toki K, Takahara S, Okuyama A.
    Clin Transplant; 2005 Oct 27; 19(5):616-21. PubMed ID: 16146552
    [Abstract] [Full Text] [Related]

  • 12. Tacrolimus as intervention in the treatment of hyperlipidemia after liver transplant.
    Roy A, Kneteman N, Lilly L, Marotta P, Peltekian K, Scudamore C, Tchervenkov J.
    Transplantation; 2006 Aug 27; 82(4):494-500. PubMed ID: 16926593
    [Abstract] [Full Text] [Related]

  • 13. Improved attainment of NKF classified lipid target levels after conversion from cyclosporine to tacrolimus in renal graft recipients.
    Pohanka E, Margreiter R, Sparacino V, Sperschneider H, European Switch to Tacrolimus Study Group.
    Transplant Proc; 2005 May 27; 37(4):1874-6. PubMed ID: 15919490
    [Abstract] [Full Text] [Related]

  • 14. Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients.
    Kobashigawa JA, Patel J, Furukawa H, Moriguchi JD, Yeatman L, Takemoto S, Marquez A, Shaw J, Oeser BT, Subherwal S, Wu GW, Kawano J, Laks H.
    J Heart Lung Transplant; 2006 Apr 27; 25(4):434-9. PubMed ID: 16563974
    [Abstract] [Full Text] [Related]

  • 15. Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight.
    Neal DA, Gimson AE, Gibbs P, Alexander GJ.
    Liver Transpl; 2001 Jun 27; 7(6):533-9. PubMed ID: 11443583
    [Abstract] [Full Text] [Related]

  • 16. Tacrolimus versus cyclosporine microemulsion for heart transplant recipients: a meta-analysis.
    Ye F, Ying-Bin X, Yu-Guo W, Hetzer R.
    J Heart Lung Transplant; 2009 Jan 27; 28(1):58-66. PubMed ID: 19134532
    [Abstract] [Full Text] [Related]

  • 17. The impact on biochemical profiles and allograft function for patients converted from cyclosporine to tacrolimus after clinical heart transplantation.
    Wang CH, Chou NK, Ko WJ, Chi NH, Tsao CI, Wang SS.
    Transplant Proc; 2008 Oct 27; 40(8):2600-2. PubMed ID: 18929812
    [Abstract] [Full Text] [Related]

  • 18. Lipid profiles in pediatric thoracic transplant recipients are determined by their immunosuppressive regimens.
    Law YM, Yim R, Agatisa P, Boyle GJ, Miller SA, Lawrence K, Webber SA.
    J Heart Lung Transplant; 2006 Mar 27; 25(3):276-82. PubMed ID: 16507419
    [Abstract] [Full Text] [Related]

  • 19. Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications?
    Badiou S, Garrigue V, Dupuy AM, Chong G, Cristol JP, Mourad G.
    Transplant Proc; 2006 Sep 27; 38(7):2314-6. PubMed ID: 16980076
    [Abstract] [Full Text] [Related]

  • 20. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G, Grazi GL, Sanjuan F, Wu Y, Mühlbacher F, Samuel D, Friman S, Jones R, Cantisani G, Villamil F, Cillo U, Clavien PA, Klintmalm G, Otto G, Pollard S, McCormick PA.
    Liver Transpl; 2006 Oct 27; 12(10):1464-72. PubMed ID: 17004259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.